ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

FDA Issues Safety Alerts for Bisphosphonates & SGLT2 Inhibitors

Michele B. Kaufman, PharmD, BCGP  |  May 20, 2015

Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…

Progress Made in Search for a Fibromyalgia Biomarker

Lara C. Pullen, PhD  |  May 15, 2015

Fibromyalgia syndrome (FMS), rheumatoid arthritis (RA) and spondyloarthritis (SpA) all exhibit multifaceted manifestations, and many patients exhibit overlapping comorbidities. However, patients with FMS are distinct from others in that they experience widespread pain, fatigue and mood changes, including anxiety and depression. Although its hallmark symptom of pain causes rheumatologists to consider FMS a pain disorder,…

Health Data Breaches on the Rise

Kathryn Doyle (Reuters Health)  |  April 15, 2015

Large-scale health data breaches reported by doctors and health plans have been rising steadily, a new report shows. From 2010 to 2013, nearly 1000 large breaches affected more than 29 million individual health records, and more than half resulted from theft or loss of laptops, thumb drives and paper records, according to researchers with access…

Listen Now: Remembering Medicine’s Past

Carol Patton  |  April 2, 2015

Collector Donah Zack Crawford talks about early surgical instruments, medical techniques, and leeches too!

Atherosclerosis Insights May Shed Light on Lupus

Lara C. Pullen, PhD  |  March 20, 2015

New research compares pathogenic immune response in SLE with immune response that contributes to atherosclerotic plaque

The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market

Richard Quinn  |  March 17, 2015

With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases

Infliximab, Tocilizumab Can Help in Large Vessel Vasculitis

Lara C. Pullen, PhD  |  March 13, 2015

Case studies show some patients with LVV can achieve remission after treatment with biological agents

Atherosclerosis, Cardiovascular Disease More Common in Patients with Primary Sjögren’s Syndrome

Lara C. Pullen, PhD  |  March 6, 2015

Study adds to research linking increased risk of morbidity, early mortality from CV events among patients with systemic autoimmune diseases

Case Report: Contagious Rash in Active Systemic Lupus Erythematosus

Kenneth W. Van Dyke, DO, Jen K. Erbil, MD, and Harmanjot K. Grewal, MD  |  March 1, 2015

Consider a diagnosis of crusted scabies in immunosuppressed patients who develop a persistent, pruritic rash

Rat Model of Arthritis Sheds Light on How Disease Affects Bone

Lara C. Pullen, PhD  |  February 27, 2015

Increased bone turnover, mineral loss among signs of bone damage found in disease-induced rats

  • « Previous Page
  • 1
  • …
  • 314
  • 315
  • 316
  • 317
  • 318
  • …
  • 332
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences